Amblyotech
closedDeveloper of novel electronic media therapies designed for the treatment of amblyopia and other ocular diseases.
Launch date
Market cap
-
Enterprise valuation
AUD2—4m (Dealroom.co estimates Jan 2018.)
Atlanta Georgia (HQ)